Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Boric Acid, Calcium, Magnesium
Norbrook Laboratories Limited
QA12AA20
Boric Acid, Calcium, Magnesium
Solution for injection
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Cattle
Mineral deficiency
Expired
2005-08-03
Revised: September 2010 AN: 00348/2010 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Downland Low Volume Calcium Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE(S) Each 100 ml contains 4.2g calcium (provided by calcium gluconate, calcium borogluconate and calcium hydroxide) and 0.78g magnesium (provided by magnesium chloride hexahydrate). Also contains 7.34% w/v boric acid. For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for Injection. A clear, colourless to pale yellow solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Indicated in the treatment of hypocalcaemia in cattle complicated by a deficiency of magnesium. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES In cases of acute hypomagnesaemia the administration, by appropriate routes, of a solution with a higher concentration of magnesium may be necessary. Revised: September 2010 AN: 00348/2010 Page 2 of 4 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The product does not contain an antimicrobial preservative. Any solution remaining in the vial following withdrawal of required dose should be discarded. Solutions for intravenous injection should be warmed to body temperature and infused slowly. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Care should be taken to avoid accidental self-injection: may cause irritation at site of injection. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Rapid intravenous injection may result in cardiac arrythmias and in severely toxaemic cows, collapse and death. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Provided the above precautions are observed the product should be safe for use during pregnancy and lactation. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None recorded. 4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATIO Read the complete document